Screener
Sarepta Therapeutics, Inc. SRPT Interest Income
Interest Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Interest income | $6,207 | $5,254 | $12,567 | $15,444 |
| Accretion of investment discount, net | 955 | 1,887 | 1,597 | 4,125 |
| Interest expense | (21,508) | (5,228) | (43,221) | (9,731) |
| (Loss) gain on strategic investments | (448) | 36,721 | (2,160) | (54,007) |
| Other, net | (246) | (573) | 918 | (902) |
| Total other (expense) income, net | $(15,040) | $38,061 | $(30,299) | $(45,071) |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s interest income?
- Sarepta Therapeutics, Inc. (SRPT) reported interest income of $6.21M in Q2 2026.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Sarepta Therapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude